
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ZIP10 CRISPR/Cas9 KO Plasmid (h) | sc-406811 | 20 µg | $397.00 |
SLC39A10 encodes ZIP10, a plasma membrane zinc influx transporter in the SLC39/ZIP family that regulates cytosolic Zn2+ availability for metalloenzyme activity, zinc-finger transcription factors, and redox-sensitive signaling. By controlling zinc homeostasis, ZIP10 influences pathways linked to cell proliferation, differentiation, and stress responses, including signaling cascades shaped by zinc-dependent modulation of kinase and phosphatase activities. Altered ZIP10 expression or zinc handling has been associated in the literature with immune cell function, epithelial biology, and tumor-related phenotypes, reflecting the broad dependence of cellular programs on zinc availability. These features make SLC39A10 a relevant target for mechanistic studies of zinc-regulated signaling networks and metal ion transport biology.
ZIP10 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SLC39A10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SLC39A10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SLC39A10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ZIP10 protein expression.
This CRISPR knockout system enables efficient generation of SLC39A10-deficient cell models for investigation of ZIP10 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.